Treatment of Hypophosphatemic Rickets in Nephropathic Cystinosis with Fanconi Syndrome (CTNS Mutation)

This clinical scenario concerns patients with nephropathic cystinosis — a lysosomal storage disease driven by CTNS gene mutations — in whom proximal tubular dysfunction produces Fanconi syndrome and, as a consequence, hypophosphatemic rickets.

Clinical Scenario

Nephropathic cystinosis results from CTNS mutations causing cystine accumulation in the proximal tubule, leading to Fanconi syndrome and progressive chronic kidney disease. The renal tubular wasting that characterises Fanconi syndrome drives urinary losses of water, bicarbonate, and phosphate — ultimately producing hypophosphatemic rickets.

Management Overview

The approach targets both the metabolic consequences of Fanconi syndrome and the underlying cystinosis. Central to management is replacement of the urinary losses responsible for hypophosphatemia, alongside nutritional support and vitamin D strategies. Addressing the underlying lysosomal storage defect is also a component of the overall plan — the complete structured regimen specifies each element in full.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1007/s00467-022-05505-5

Nephropathic cystinosis is a lysosomal storage disease due to mutations in CTNS resulting in cystine accumulation in the proximal tubule and consecutive Fanconi syndrome and progressive chronic kidney disease which can be ameliorated by cysteamine therapy.
Treatment of hypophosphatemic rickets primarily focuses on replacement of urinary losses due to Fanconi syndrome including water, bicarbonate, and phosphate which varies greatly.
Patients require adequate caloric and protein intake, supplementation with native vitamin D for vitamin D deficiency, calcium supplementation in cases of persistent hypocalcemia and treatment with active vitamin D to help cure rickets.

View source ↗